Trademark: MEMSOLA 1403275
Word
MEMSOLA
ID
1403275
Trademark Type
Word
Status
Removed
Not renewed: Renewal fee not paid
Not renewed: Renewal fee not paid
Application Date
07 January 2011
Registration Date
07 January 2011
Service
Spruson & Ferguson
Goods and Services:
Class 5:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer/oncology; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders including atherosclerosis, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders including Alzheimer's, neurological disorders including anxiety spectrum disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of autoimmune disorders
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer/oncology; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders including atherosclerosis, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders including Alzheimer's, neurological disorders including anxiety spectrum disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of autoimmune disorders